Niki BioSolutions Total Assets Growth & History (NIKI)
Niki BioSolutions's total assets was $18.7M for fiscal 2025.
View full Niki BioSolutions company overviewNiki BioSolutions annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18.7M | $2.6M | +15.88% |
| 2024 | 2024-12-31 | $16.1M | −$4.5M | −21.85% |
| 2023 | 2023-12-31 | $20.6M | −$227,280 | −1.09% |
| 2022 | 2022-12-31 | $20.9M | −$1.0M | −4.75% |
| 2021 | 2021-12-31 | $21.9M | −$22.3M | −50.47% |
| 2020 | 2020-12-31 | $44.2M | $20.3M | +84.65% |
| 2019 | 2019-12-31 | $24.0M | −$21.1M | −46.86% |
| 2018 | 2018-12-31 | $45.1M | $13.5M | +42.82% |
| 2017 | 2017-12-31 | $31.6M | — | — |
Niki BioSolutions quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $18.7M | $2.6M | +15.88% |
| Q3 2025 | 2025-09-30 | $17.6M | — | — |
| Q2 2025 | 2025-06-30 | $18.1M | $399,821 | +2.26% |
| Q4 2024 | 2024-12-31 | $16.1M | −$4.5M | −21.85% |
| Q2 2024 | 2024-06-30 | $17.7M | $3.3M | +22.85% |
| Q4 2023 | 2023-12-31 | $20.6M | −$227,280 | −1.09% |
| Q2 2023 | 2023-06-30 | $14.4M | −$9.6M | −40.00% |
| Q4 2022 | 2022-12-31 | $20.9M | −$1.0M | −4.75% |
| Q2 2022 | 2022-06-30 | $24.0M | −$7.7M | −24.27% |
| Q4 2021 | 2021-12-31 | $21.9M | −$22.3M | −50.47% |
| Q2 2021 | 2021-06-30 | $31.7M | $8.4M | +36.06% |
| Q4 2020 | 2020-12-31 | $44.2M | $20.3M | +84.65% |
| Q2 2020 | 2020-06-30 | $23.3M | — | — |
| Q4 2019 | 2019-12-31 | $24.0M | −$21.1M | −46.86% |
| Q4 2018 | 2018-12-31 | $45.1M | $13.5M | +42.82% |
| Q4 2017 | 2017-12-31 | $31.6M | — | — |
Niki BioSolutions total assets trends
Over the last five fiscal years, Niki BioSolutions's total assets decreased from $44.2M to $18.7M, a change of −$25.5M. The latest reported quarter, Q4 2025, shows $18.7M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Niki BioSolutions source filings ↗